Aberrant splicing of FHIT transcripts in human gastric cancer cell lines

Sang-Han Lee1, Ho-Young Kim, Tae-Jung Kim

  • 1Department of Biochemistry, College of Medicine, Soonchunhyang University, Cheon-An 330-090, Korea. L1037624@sch.ac.kr

Research Communications in Molecular Pathology and Pharmacology
|April 15, 2004
PubMed

Insights

Faulty splicing of the FHIT gene generates aberrant transcripts in gastric cancer cell lines. These FHIT gene alterations may contribute to cancer development by disrupting normal gene function.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Alterations in the FHIT gene are common in human cancers.
  • Wild-type FHIT gene replacement can suppress tumor formation in FHIT-negative cells.
  • Aberrant FHIT transcripts are found in various solid tumors.

Purpose of the Study:

  • To identify aberrant FHIT transcripts in gastric cancer cell lines.
  • To characterize the nature and origin of these aberrant transcripts.

Main Methods:

  • Nested reverse transcription-polymerase chain reaction (RT-PCR) was used.
  • Sequence analysis was performed on identified transcripts.

Main Results:

  • All 6 gastric cancer cell lines examined showed small-sized FHIT transcripts alongside wild-type.
  • Truncated transcripts included exonic deletions and intron insertions, often lacking the translation initiation codon in exon 5.
  • Aberrant transcripts resulted from faulty splicing, including exon skipping and cryptic splice site activation.

Conclusions:

  • Gastric cancer cell lines exhibit aberrant FHIT transcripts due to complex faulty splicing mechanisms.
  • These splicing defects, including exon skipping and cryptic splice site usage, are prevalent in gastric cancer.
  • The identified aberrant FHIT transcripts may play a role in the pathogenesis of gastric cancer.